UNITEDHEALTH GROUP INC (UNH) earnings date, results and what the price requires
NYSE · SEC CIK 0000731766 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Sep 30, 2026 | Oct 13, 2026 | Announced; figures arrive with the 10-Q | — | — | Filing |
| Jun 30, 2026 | Jul 16, 2026 | $112.03B | $5.48B | $6.04 | Filing |
| Mar 31, 2026 | Apr 21, 2026 | $111.72B | $6.28B | $6.90 | Filing |
| Dec 31, 2025 | Jan 27, 2026 | $113.22B | $10.0M | $0.05 | Filing |
| Sep 30, 2025 | Oct 28, 2025 | $113.16B | $2.35B | $2.59 | Filing |
| Jun 30, 2025 | Jul 29, 2025 | $111.62B | $3.41B | $3.74 | Filing |
| Mar 31, 2025 | Apr 17, 2025 | $109.58B | $6.29B | $6.85 | Filing |
| Dec 31, 2024 | Jan 16, 2025 | $100.81B | $5.54B | $5.99 | Filing |
| Sep 30, 2024 | Oct 15, 2024 | $100.82B | $6.05B | $6.51 | Filing |
What would UNITEDHEALTH GROUP INC have to report for its valuation to change?
At $406.67, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 17.4% a year, to $34.76. On that path the next quarter needs diluted EPS near $3.04, against $2.59 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 17.4% | 17.4% |
| EPS needed in final year | $34.76 | $34.76 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. UNH goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.